UK markets open in 42 minutes
NIKKEI 225
38,751.11 +515.04 (+1.35%) HANG SENG
18,502.17 -76.13 (-0.41%) CRUDE OIL
78.64 +0.16 (+0.20%) GOLD FUTURES
2,327.80 -3.40 (-0.15%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,673.90 -724.14 (-1.41%)
BEAM Dec 2024 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:58AM EDT. Market open.
| Previous close | 3.6000 |
| Open | 3.5000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 30.00 |
| Expiry date | 2024-12-20 |
| Day's range | 3.4000 - 3.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksUltragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
Ultragenyx (RARE) delivered earnings and revenue surprises of -18.02% and 4.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksBeam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Beam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.